<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Stub><StubValue>Control</StubValue></Stub><HeaderValue>G2–M</HeaderValue></NavigationPath><value>10.2±1.0</value><CellType>Partially Numeric</CellType></Cell><Table><TableType>Matrix</TableType><tableName>Cell cycle distribution of human colon carcinoma HT-29 cells exposed to different combinations of SN-38 and FU</tableName><tableOrder>Table 2</tableOrder><tableFooter/></Table><Document><DocumentTitle>Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial</DocumentTitle><PMC>2360198</PMC></Document></information>